Rare CFTR mutation 1525-1G>A in a Pakistani patients

Journal of Tropical Pediatrics

Volumn 50, Issue 2, 2004, Pages 120-122

  Wahab, Atiqa Abdul ^a   Al Thani, G ^a   Dawod, S T ^a   Kambouris, M ^b   Al Hamed, M ^b  

^a HAMAD MEDICAL CORPORATION   (Qatar)

^b KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; PANCREAS ENZYME; SALBUTAMOL; TRANSMEMBRANE CONDUCTANCE REGULATOR;

ARTICLE; CASE REPORT; CLINICAL FEATURE; CYSTIC FIBROSIS; DNA POLYMORPHISM; ENZYME REPLACEMENT; ETHNOLOGY; GENE MUTATION; GENETIC ANALYSIS; HUMAN; INTRON; MALE; PAKISTAN; PANCREAS INSUFFICIENCY; PHENOTYPE; PHYSIOTHERAPY; PRESCHOOL CHILD; RESPIRATORY TRACT DISEASE; RESPIRATORY TRACT INFECTION; THORAX RADIOGRAPHY;

CHILD, PRESCHOOL; CYSTIC FIBROSIS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; FATAL OUTCOME; HUMANS; MALE; MUTATION; PAKISTAN; PHENOTYPE;

EID: 1842419605     PISSN: 01426338     EISSN: None     Source Type: Journal    
DOI: 10.1093/tropej/50.2.120     Document Type: Article

References (15)

1. Welsh MJ, Tsui LC, Boat TF, Beaudet AL. Cystic fibrosis. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds), The Metabolic and Molecular Bases of Inherited Disease, 7th edn, McGraw Hill, New York, 1995; 3799-876.
2. Goodchild MC, Insly J, Rushton DI, Gase H. Cystic fibrosis in three Pakistani Children. Arch Dis Child 1974; 49: 739-41.
3. Kambouris M, Banjar H, Mogarri I, Nazer H, Al-Hamed M, Meyer BF. Identification of novel mutatons in Arabs with cystic fibrosis and their impact on the cystic fibrosis transmembrane regulator mutation detection rate in Arab population. Eur J Pediatr 2000; 159: 303-9.
4. Kambouris M, Jacson CE, Feldman GL. Diagnosis of multiple endocrine neoplasia [MEN] 2A, 2B and familial medullary thyroid carcinoma [FMTC] by multiplex PCR and heteroduplex analyses of RET proto-oncogene mutations. Hum Mutat 1996; 8: 64-70.
5. Kerem BS, Rommens JM, Buchman JA, et al. Identification of the cystic fibrosis gene: Genetic analysis. Science 1989; 245: 1073-80.
6. European Working Group of CF genetics. Gradient in Europe of the major CF mutation and of its associated haplotype. Hum Genet 1990; 85: 436-45.
7. Lewis A. The epidemiology of cystic fibrosis. In: Hodson ME, Geddes DM (eds), Cystic Fibrosis. Chapman and Hall, London, 1995; 2-4.
8. Nazer H, Riff E, Sakati N, Mathew R, Majeed MA, Harfi H. Cystic fibrosis in Saudi Arabia. Eur J Pediatr 1989; 148: 330-33.
9. Abdul Wahab A, Dawod ST, Al Thani G, Kambouris M. Al Hamed M. Heterogeneity of the cystic fibrosis phenotype in large kindred family in Qatar with cystic fibrosis mutation (11234V). J Trop Pedatr 2001; 47: 110-12.
10. Frossard PM, Hericant J, Bossaert Y, Dawson KP. Genotype-phenotype correlations in cystic fibrosis: Clinical severity of mutations S549R (T>G). Eur Repir J 1999; 13: 100-2.
11. Frossard PM, Dawson KP, Das SJ, Alexander PC, Girodon E, Goossens M. Identification of cystic fibrosis mutation in Oman. Clin Genet 2000; 57: 235-36.
12. Schwarz MJ, Super M, Wallis C, et al. ΔF508 testing of the DNA bank of the Royal Manchester Children's Hospital. Hum Genet 1990; 85: 428-30.
13. Malone G, Haworth A, Schwartz MJ, Cuppens H, Super M. Detection of five novel mutations of the cystic fibrosis transmembrane regulator (CFTR) gene in Pakistani patients with cystic fibrosis. Y569D, Q98X, 296+12 (T>C), 1161delC and 621+2 (T>C). Hum Mutat 1998; 11: 152-57.
14. Powers CA, Potter EM, Wessel HU, Lloyd-Still JD. Cystic fibrosis in Asian Indians. Arch Pediatr Adolesc Med 1996; 150: 554-55.
15. Dork T, Wulbrand U, Tummler B. Four novel cystic fibrosis in splice junction sequence affecting the CFTR nucleotide binding folds. Genomics 1993; 15: 688-69.